CHU UCL Namur - Site de Sainte-Elisabeth — Namur

Public research footprint of CHU UCL Namur - Site de Sainte-Elisabeth, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Head and Neck Squamous Cell Carcinoma (HNSCC) · Breast Cancer · Advanced/Metastatic Solid Tumors · Gastroesophageal-junction Cancer

Recently updated registry entries

NCT03526835 — A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors (Recruiting)
NCT05696626 — Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined… (Recruiting)
NCT06295731 — INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU UCL Namur - Site de Sainte-Elisabeth?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.